Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis

Life Sciences

Volumn 118, Issue 1, 2014, Pages 39-45

  Zhang, Yujie ^a   Meng, Zhaowei ^a   Zhang, Mingfang ^b   Tan, Jian ^a   Tian, Weijun ^a   He, Xianghui ^a   Fu, Qiang ^a   Xu, Ke ^a   He, Qing ^a   Zhu, Mei ^a   Li, Xue ^a   Zhang, Guizhi ^a   He, Yajing ^a   Jia, Qiang ^a   Zhang, Jianping ^a   Wang, Sheng ^a   Song, Xinghua ^a,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Midkine (MK); Multi nodular goiter (MNG); Nuclear factor kappa B (NF B); Papillary thyroid cancer (PTC); Receiver operating characteristic (ROC) curves; Synchronous metastasis

Indexed keywords

KI 67 ANTIGEN; MIDKINE; TRANSCRIPTION FACTOR RELA; MDK PROTEIN, HUMAN; NERVE GROWTH FACTOR; RELA PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; METASTASIS; NODULAR GOITER; PROTEIN EXPRESSION; THYROID CARCINOMA; WESTERN BLOTTING; ADULT; CARCINOMA; EVALUATION STUDY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; THYROID TUMOR;

ADULT; CARCINOMA; FEMALE; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TRANSCRIPTION FACTOR RELA; TUMOR MARKERS, BIOLOGICAL;

EID: 84909956819     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.09.025     Document Type: Article

References (65)

1. C.A. Benbassat, S. Mechlis-Frish, and D. Hirsch Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer World J Surg 30 2006 1088 1095
2. P.R. Bhargav, A. Mishra, G. Agarwal, A. Agarwal, P.K. Pradhan, and S. Gambhir Long-term outcome of differentiated thyroid carcinoma: experience in a developing country World J Surg 34 2010 40 47
3. L.S. Caminha, D.P. Momesso, F. Vaisman, R. Corbo, and M. Vaisman Long-term follow-up of patients with differentiated thyroid cancer who had negative 131I whole-body scan at first evaluation after treatment Clin Nucl Med 38 2013 765 769
4. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, and S.J. Mandel Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
5. F.I. Dimitrakopoulos, A.G. Antonacopoulou, A. Kottorou, H. Vlotinou, N.D. Panagopoulos, and D. Dougenis NSCLC and the alternative pathway of NF-kappaB: uncovering an unknown relation Virchows Arch 460 2012 515 523
6. C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, and J.P. Travagli Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2006 2892 2899
7. H.C. Fiegel, J.T. Kaifi, R. Wachowiak, A. Quaas, K. Aridome, and K. Ichihara-Tanaka Midkine is highly expressed in neuroblastoma tissues Pediatr Surg Int 24 2008 1355 1359
8. P.O. Gannon, L. Lessard, L.M. Stevens, V. Forest, L.R. Begin, and S. Minner Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer Eur J Cancer 49 2013 2441 2448
9. A.K. Garg, A. Jhingran, A.H. Klopp, B.B. Aggarwal, A.B. Kunnumakkara, and R.R. Broadus Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation Int J Radiat Oncol Biol Phys 78 2010 1331 1336
10. R. Ghosh, J.E. Gilda, and A.V. Gomes The necessity of and strategies for improving confidence in the accuracy of western blots Expert Rev Proteomics 1-12 2014
11. H. Hao, Y. Maeda, T. Fukazawa, T. Yamatsuji, M. Takaoka, and X.H. Bao Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer PLoS One 8 2013 e71093
12. I.C. Huang, F.F. Chou, R.T. Liu, S.C. Tung, J.F. Chen, and M.C. Kuo Long-term outcomes of distant metastasis from differentiated thyroid carcinoma Clin Endocrinol (Oxf) 76 2012 439 447
13. B.C. Jham, N.L. Costa, J.M. Silva, A.C. de Miranda, J.C. Oliveira, and T.A. Silva Midkine expression in oral squamous cell carcinoma and leukoplakia J Oral Pathol Med 41 2012 21 26
14. D.R. Jones Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases Br J Pharmacol 171 12 2014 2925 2939
15. K. Kadomatsu, M. Tomomura, and T. Muramatsu cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis Biochem Biophys Res Commun 151 1988 1312 1318
16. J.T. Kaifi, H.C. Fiegel, S.L. Rafnsdottir, K. Aridome, P.G. Schurr, and U. Reichelt Midkine as a prognostic marker for gastrointestinal stromal tumors J Cancer Res Clin Oncol 133 2007 431 435
17. M.R. Kang, M.S. Kim, S.S. Kim, C.H. Ahn, N.J. Yoo, and S.H. Lee NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas Pathology 41 2009 622 625
18. M. Kato, H. Maeta, S. Kato, T. Shinozawa, and T. Terada Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma Mod Pathol 13 2000 1060 1065
19. M. Kato, T. Shinozawa, S. Kato, A. Awaya, and T. Terada Increased midkine expression in hepatocellular carcinoma Arch Pathol Lab Med 124 2000 848 852
20. M. Kato, T. Shinozawa, S. Kato, K. Endo, and T. Terada Increased midkine expression in intrahepatic cholangiocarcinoma: immunohistochemical and in situ hybridization analyses Liver 20 2000 216 221
21. H.C. Kwon, S.H. Kim, S.Y. Oh, S. Lee, K.A. Kwon, and J.H. Lee Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer Cancer Sci 101 2010 1557 1561
22. L. Lessard, P.I. Karakiewicz, P. Bellon-Gagnon, M. Alam-Fahmy, H.A. Ismail, and A.M. Mes-Masson Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases Clin Cancer Res 12 2006 5741 5745
23. X. Li, A.B. Abdel-Mageed, D. Mondal, and E. Kandil The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers Thyroid 23 2 2013 209 218
24. Y. Li, Y. Pan, R. Wang, Y. Sun, H. Hu, and X. Shen ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR PLoS One 8 2013 e69016
25. Y.M. Long, S. Ye, J. Rong, and W.R. Xie Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma World J Gastroenterol 14 2008 4739 4744
26. S. Maeda, H. Shinchi, H. Kurahara, Y. Mataki, H. Noma, and K. Maemura Clinical significance of midkine expression in pancreatic head carcinoma Br J Cancer 97 2007 405 411
27. H. Maehara, T. Kaname, K. Yanagi, H. Hanzawa, I. Owan, and T. Kinjou Midkine as a novel target for antibody therapy in osteosarcoma Biochem Biophys Res Commun 358 2007 757 762
28. K. Matusan-Ilijas, G. Damante, D. Fabbro, G. Dordevic, I. Hadzisejdic, and M. Grahovac Osteopontin expression correlates with nuclear factor-kappaB activation and apoptosis downregulation in clear cell renal cell carcinoma Pathol Res Pract 207 2011 104 110
29. P. McCall, J. Catlow, P.A. McArdle, D.C. McMillan, and J. Edwards Tumoral C-reactive protein and nuclear factor kappa-B expression are associated with clinical outcome in patients with prostate cancer Cancer Biomark 10 2011 91 99
30. Z. Meng, N. Mitsutake, M. Nakashima, D. Starenki, M. Matsuse, and S. Takakura Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cells Endocrinology 149 2008 5357 5365
31. Z. Meng, S. Lou, J. Tan, K. Xu, Q. Jia, and W. Zheng Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by I PLoS One 7 2012 e33597
32. Z. Meng, S. Lou, J. Tan, K. Xu, Q. Jia, and W. Zheng Nuclear factor-kappa B inhibition can enhance therapeutic efficacy of 131I on the in vivo management of differentiated thyroid cancer Life Sci 91 2012 1236 1241
33. P.G. Milner, Y.S. Li, R.M. Hoffman, C.M. Kodner, N.R. Siegel, and T.F. Deuel A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence Biochem Biophys Res Commun 165 1989 1096 1103
34. T. Muramatsu Structure and function of midkine as the basis of its pharmacological effects Br J Pharmacol 171 2014 814 826
35. H. Muramatsu, and T. Muramatsu Purification of recombinant midkine and examination of its biological activities: functional comparison of new heparin binding factors Biochem Biophys Res Commun 177 1991 652 658
36. Y. Nariai, K. Mishima, Y. Yoshimura, and J. Sekine FAP-1 and NF-kappaB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis Int J Oral Maxillofac Surg 40 2011 419 426
37. K. Ota, H. Fujimori, M. Ueda, H. Jono, S. Shinriki, and T. Ota Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma Int J Oncol 37 2010 797 804
38. F. Pacifico, and A. Leonardi NF-kappaB in solid tumors Biochem Pharmacol 72 2006 1142 1152
39. F. Pacifico, and A. Leonardi Role of NF-kappaB in thyroid cancer Mol Cell Endocrinol 321 2010 29 35
40. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, and W. Wiersinga European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 2006 787 803
41. N.D. Perkins The diverse and complex roles of NF-kappaB subunits in cancer Nat Rev Cancer 12 2012 121 132
42. H. Rauvala An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors EMBO J 8 1989 2933 2941
43. Y.J. Ren, and Q.Y. Zhang Expression of midkine and its clinical significance in esophageal squamous cell carcinoma World J Gastroenterol 12 2006 2006 2010
44. J.S. Ross, B.V. Kallakury, C.E. Sheehan, H.A. Fisher, R.P. Kaufman Jr., and P. Kaur Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence Clin Cancer Res 10 2004 2466 2472
45. M. Ruan, T. Ji, Z. Wu, J. Zhou, and C. Zhang Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis Int J Oral Maxillofac Surg 36 2007 159 164
46. K. Sakamoto, and K. Kadomatsu Midkine in the pathology of cancer, neural disease, and inflammation Pathol Int 62 2012 445 455
47. M.A. Scheper, E.C. Duarte, C. Intapa, M. Zhang, L.M. Nascimento, and T.P. Almeida Expression of midkine in ameloblastomas and its correlation with clinicopathologic parameters Oral Surg Oral Med Oral Pathol Oral Radiol 114 2012 497 502
48. H. Shao, X. Yu, C. Wang, Q. Wang, and H. Guan Midkine expression is associated with clinicopathological features and BRAF mutation in papillary thyroid cancer Endocrine 46 2 2014 285 291
49. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
50. F.A. Sinicrope, S.B. Ruan, K.R. Cleary, L.C. Stephens, J.J. Lee, and B. Levin bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis Cancer Res 55 1995 237 241
51. D.V. Starenki, H. Namba, V.A. Saenko, A. Ohtsuru, S. Maeda, and K. Umezawa Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin Clin Cancer Res 10 2004 6821 6829
52. T. Sueyoshi, H. Jono, S. Shinriki, K. Ota, T. Ota, and M. Tasaki Therapeutic approaches targeting midkine suppress tumor growth and lung metastasis in osteosarcoma Cancer Lett 316 2012 23 30
53. Y. Takei, K. Kadomatsu, S. Matsuo, H. Itoh, K. Nakazawa, and S. Kubota Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells Cancer Res 61 2001 8486 8491
54. Y. Takei, K. Kadomatsu, T. Goto, and T. Muramatsu Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts Cancer 107 2006 864 873
55. W. Tokuyama, T. Mikami, M. Fujiwara, T. Matsui, and I. Okayasu Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones Pathol Int 57 2007 260 267
56. Y. Tong, R. Mentlein, R. Buhl, H.H. Hugo, J. Krause, and H.M. Mehdorn Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas J Neurochem 100 2007 1097 1107
57. J. Wang, Y. Cai, Y. Dong, J. Nong, L. Zhou, and G. Liu Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR PLoS One 9 2014 e101551
58. Y.C. Wu, I.C. Chang, C.L. Wang, T.D. Chen, Y.T. Chen, and H.P. Liu Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan PLoS One 8 2013 e70839
59. H. Yang, Z. Meng, C. Zhang, P. Zhang, and Q. Wang Establishing a new rat model of central venous sinus thrombosis and analyzing its pathophysiological and apoptotic changes J Neurosci Methods 203 2012 130 135
60. K. Yoshida, R. Sasaki, H. Nishimura, Y. Okamoto, Y. Suzuki, and T. Kawabe Nuclear factor-kappaB expression as a novel marker of radioresistance in early-stage laryngeal cancer Head Neck 32 2010 646 655
61. Z. You, Y. Dong, X. Kong, L.A. Beckett, R. Gandour-Edwards, and J. Melamed Midkine is a NF-kappaB-inducible gene that supports prostate cancer cell survival BMC Med Genomics 1 2008 6
62. H.G. Yu, L.L. Yu, Y. Yang, H.S. Luo, J.P. Yu, and J.J. Meier Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis Oncology 65 2003 37 45
63. L. Yu, Y. Fan, B. Chen, Y. Hu, Y. Gao, and D. Wei Suppression of metastasis of human pancreatic cancer cells to the liver by small interfering RNA-mediated targeting of the midkine gene Oncol Lett 6 2013 1338 1342
64. P.L. Zhang, P.K. Pellitteri, A. Law, P.A. Gilroy, G.C. Wood, and T.L. Kennedy Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis Mod Pathol 18 2005 924 932
65. Z.Q. Zhao, S. Yang, and H.S. Lu Expression of midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival Mol Med Rep 5 2012 415 419